Amgen Inc. buy Argus
Start price
30.12.25
/
50%
€280.15
Target price
30.12.26
€305.71
Performance (%)
1.42%
Price
08.05.26
€281.60
Summary
This prediction is currently active. The BUY prediction by Argus shows slight gains of 1.42%. Dividends of €2.52 are taken into consideration when calculating the performance. This prediction currently runs until 30.12.26. The prediction end date can be changed by Argus at any time. Argus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | -4.559% | -4.559% |
| iShares Core DAX® | 0,22 % | 1,49 % |
| iShares Nasdaq 100 | 6,05 % | 16,19 % |
| iShares Nikkei 225® | 5,72 % | 11,69 % |
| iShares S&P 500 | 2,17 % | 8,06 % |
Comments by Argus for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Argus from $310.00 to $360.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat